Eiger Biopharmaceuticals Inc (EIGR) Financials

$2.27

$-- (--%)

As on 10-May-2024 09:30EDT

Market cap

$3 Mln

Revenue (TTM)

$16 Mln

P/E Ratio

--

P/B Ratio

0.9

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	15.77	13.48	12.14	5.74	--	--
Cost of Revenue	0.02	1.84	0.75	0.65	0.49	0.05
Gross Profit	15.75	11.65	11.40	-0.65	-0.49	-0.05
Operating Expenses	87.54	104.39	88.34	62.15	68.90	51.05
Operating Profit (EBIT)	-71.79	-92.74	-76.94	-62.15	-68.90	-51.05
Other Income	--	0.12	46.65	0.69	2.06	0.99
Profit before Tax	-74.96	-96.75	-33.85	-65.05	-70.25	-52.39
Provision for Tax	0.01	0.02	0.06	3.58	3.39	0.99
Profit after Tax (Net Income)	-74.96	-96.78	-33.92	-68.63	-73.64	-52.39
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	-96.78	-33.92	-65.05	-70.25	-52.39

Liabilities ($ Mln)	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	-14.46	55.31	72.40	95.04	56.48	66.59
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	39.71	24.10	31.93	31.71	25.83
Current Liabilities	53.28	25.12	29.90	16.63	16.95	10.02
Total Liabilities	38.83	120.14	126.40	143.59	105.14	102.45

Assets ($ Mln)	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	0.99	2.60	23.04	5.79	4.76	0.60
Current Assets	37.84	117.54	103.36	137.81	100.38	101.85
Total Assets	38.83	120.14	126.40	143.59	105.14	102.45
Total Debt*	41.20	40.20	32.54	32.51	32.24	25.62
Net Current Assets	-15.45	92.41	73.46	121.18	83.44	91.82

Cashflow ($ Mln)	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	-74.55	-83.01	-71.34	-63.19	-63.61	-42.67
Cash Flow from Investing Activities	--	9.63	61.53	-44.79	-16.47	-29.09
Cash from Financing Activities	0.04	76.96	3.17	97.46	58.20	100.98
Net Cash Inflow / Outflow	--	3.58	-6.64	-10.51	-21.89	29.23

Financials Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	-50.76	-65.88	-1.00	-2.30	-3.01	-2.92
Cash EPS ($)	-50.25	-65.31	-0.97	-2.28	-2.99	-2.92
Adjusted Book Value ($)	--	37.65	2.13	3.18	2.31	3.71
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	-50.48	-56.51	-2.10	-2.11	-2.60	-2.38
Free Cash Flow per Share ($)	-50.64	-56.74	-3.53	-2.12	-2.62	-2.39

Profitability Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	-122.63	-96.56	-29.18	-63.47	-81.40	-80.71
ROE (%)	-367.00	-151.56	-40.51	-90.60	-119.67	-117.58
ROA (%)	-94.31	-78.51	-25.12	-55.19	-70.95	-72.10
EBIT Margin (%)	-440.57	-687.78	-633.66	-1,082.17	--	--
Net Margin (%)	-475.26	-711.43	-57.69	-1,066.56	-3,578.38	-5,318.88
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	0.17	0.11	1.11	--	--	--
EBIT Growth (%)	25.07	-20.54	-23.80	9.80	-37.49	-22.34
Net Profit Growth (%)	22.54	-185.33	50.58	6.80	-40.56	-23.42
EPS Growth (%)	0.23	-65.06	0.57	0.24	-0.03	0.33
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	0.00	-0.02	-5.20	-5.35	-4.96	-3.48
Price / Book Value	-0.02	0.03	2.44	3.86	6.46	2.74
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.23	0.62	-3.97	-4.45	-4.56	-2.15
Close Price ($)	6.75	35.40	155.70	368.70	447.00	304.80
High Price ($)	89.40	300.64	404.70	453.60	474.60	540.00
Low Price ($)	6.00	28.80	150.30	136.50	281.40	223.80
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	-2.85	0.73	0.45	0.34	0.57	0.38
Short term debt to equity ratio	-2.85	0.01	0.12	0.01	0.01	--
Current Ratio	0.71	4.68	3.46	8.29	5.92	10.16
Quick Ratio	0.68	4.57	3.37	8.28	--	--
Interest Coverage	-12.71	-22.44	-21.62	-17.29	-20.23	-21.52

Operating Efficiency Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	10.66	12.97	21.22	133.34	--	--
Asset Turnover	0.20	0.11	0.09	0.05	--	--
Receivable days	39.73	58.58	153.93	487.04	--	--
Inventory Days	33,549.73	543.30	663.09	52.66	--	--
Payable days	84,387.97	1,664.20	3,040.89	3,129.82	4,600.95	30,481.47
Cash Conversion Cycle	-50,798.51	-1,062.32	-2,223.87	-2,590.12	--	--